Understanding public procurement within the health sector: a priority in a post-COVID-19 world
Health Economics, Policy and Law · 2023-04 · 18 (2) · 172-185
DOI: 10.1017/s1744133122000184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Economics, Policy and Law, online erschienen am 27.07.2022. Verfasst von Anna García-Altés und 8 weiteren Autor:innen. Beteiligte Einrichtung: Catalan Health System Observatory, Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission.
Abstract (Originalsprache)
Every year, over 250,000 public authorities in the European Union (EU) spend about 14% of GDP on the purchase of services, works and supplies. Many are in the health sector, a sector in which public authorities are the main buyers in many countries. When these purchases exceed threshold values, EU public procurement rules apply. Public procurement is increasingly being promoted as a tool for improving efficiency and contributing to better health outcomes, and as a policy lever for achieving other government goals, such as innovation, the development of small and medium-sized enterprises, sustainable green growth and social objectives like public health and greater inclusiveness. In this paper, we describe the challenges that arise within health care systems with public procurement and identify potential solutions to them. We examined the tendering of pharmaceuticals, health technology, and e-health. In each case we identify a series of challenges relating to the complexity of the procurement process, imbalances in power on either side of transactions and the role of procurement in promoting broader public policy objectives. Finally, we recommend several actions that could stimulate better procurement, and suggest a few areas where further EU cooperation can be pursued.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Catalan Health System Observatory, Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain.
- Department of Health Services and Policy, London School of Hygiene & Tropical Medicine, London, UK.
- Department of Economics and Related Studies, University of York, York, UK.
- Nova School of Business and Economics, Universida de Nova de Lisboa, Lisboa, Portugal.
- Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
- Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
ORCID-Profile: Martin McKee
Förderung
- European Commission
Zitieren
APA
García-Altés, A., McKee, M., Siciliani, L., Barros, P. P., Lehtonen, L., Rogers, H., Kringos, D., Zaletel, J., & De Maeseneer, J. (2023). Understanding public procurement within the health sector: a priority in a post-COVID-19 world. Health Economics, Policy and Law, 18(2), 172-185. https://doi.org/10.1017/s1744133122000184
Vancouver
García-Altés A, McKee M, Siciliani L, Barros PP, Lehtonen L, Rogers H, et al. Understanding public procurement within the health sector: a priority in a post-COVID-19 world. Health Economics, Policy and Law. 2023;18(2):172-185. doi:10.1017/s1744133122000184
BibTeX
@article{GarcaAlts2023,
author = {García-Altés, Anna and McKee, Martin and Siciliani, Luigi and Barros, Pedro Pita and Lehtonen, Lasse and Rogers, Heather and Kringos, Dionne and Zaletel, Jelka and De Maeseneer, Jan},
title = {Understanding public procurement within the health sector: a priority in a post-COVID-19 world},
journal = {Health Economics, Policy and Law},
year = {2023},
volume = {18},
number = {2},
pages = {172--185},
doi = {10.1017/s1744133122000184}
}
EUVIMED